such as mutation of tumor suppressor p53, are implicated in the development of SCC. In addition, various intracellular molecules are involved in the regulation of SCC. Examples include S100A8 protein that regulates cutaneous SCC differentiation 2 . Other important contributor for SCC development and maintenance is β-catenin. Evidence shows that epidermis-specific knockout of β-catenin gene leads to the loss of cancer stem cells (or cancer initiating cells) and completes tumor regression 3 . It has been well established that β-catenin plays a central role in Wnt-initiated cellular signaling cascade. Once Wnt ligands bind to their cognate membrane receptors, cytoplasmic β-catenin accumulates and translocates to the nucleus, then triggering downstream gene expression. The expression of many β-catenin-regulated genes eventually affect the cellular status, which is linked to cancer development and maintenance. For example, β-catenin-regulated aldehyde dehyrognase 1A1 (ALDH1A1) is involved in gaining the stem cell characteristics of ovarian cancer 4 . Although the Wnt/β-catenin signaling is well recognized in various cancer cells, the downstream effectors of β-catenin in SCC are not completely identified. In this study, we attempted to identify the putative β-catenin-regulated genes in SCC.
We first investigated the putative role of β-catenin in the growth and maintenance of SCC cells, using the established human squamous cell line SCC13. The SCC13 cells were cultured from SCC of the facial epidermis of 56-year-old female who received a series of radiation treatments for several years before its surgical removal 5 . To this end, we made a recombinant adenovirus expressing wild type β-catenin. After transduction of recombinant adenovirus into SCC13 cells, the protein level for β-catenin was highly increased compared to the control group in which adenovirus expressing LacZ was transduced (Fig. 1A) . We then determined the effect of β-catenin on the growth of SCC13 cells. Overexpression of β-catenin led to the increase of cell growth compared to the control (Fig. 1B) . The clonogenic assay is used for determining the cancer stem cell characteristics 6 . In parallel with the data on cell growth, overexpression of β-catenin markedly increased SCC13 cell colony number (Fig. 1C) . These data additionally provide the evidence that β-catenin supports the growth and maintenance of SCC cells.
In an attempt to identify the genes regulated by β-catenin in SCC13 cells, we found that cAMP response element binding protein 1 (CREB) was induced by overexpression of β-catenin at the protein level ( Fig. 2A) . To investigate the potential role of CREB, we made the recombinant adenovirus expressing CREB. After adenoviral transduction into SCC13 cells, the expression of CREB was markedly increased compared to the control adenovirus-transduced cells. Overexpression of CREB, however, did not affect the protein level for β-catenin (Fig. 2B) . These result suggest that CREB is a downstream molecule of β-catenin, and that there is no reciprocal regulation between β-catenin and CREB. To evaluate whether increased CREB affects the behavior of SCC13 cells, we performed the clonogenic assay. Overexpression of CREB resulted in marked increase of clonogenicity of SCC13 cells, more than 2-fold increase of colony formation (Fig. 2C) . This data supports the role of CREB as a β-catenin downstream regulator for the growth and maintenance of SCC cells. Multiple genomic alterations, such as mutations in tumor suppressor genes or proto-oncogenes, give rise to cancer development. In addition, many of intracellular signaling cascades are strongly implicated in cancer development and progression. Examples include sonic hedgehog and Wnt/β-catenin signaling pathways 7 . In this study, we investigated the putative role of β-catenin and its downstream modulator in the growth and maintenance of SCC cells. We found that β-catenin increased the proliferative potential of SCC13 cells, and that CREB was a downstream modulator of β-catenin and had also the potential for enhancing the growth and maintenance of SCC13 cells.
In solid tumors, it has been demonstrated that rare population of tumor cells in the mass can form colonies in an in vitro clonogenic assay 8 . These specially committed cell populations are now called the cancer stem cells and/or cancer initiating cells. Because the stem cells showed the characteristics of unlimited self-renewal, several experimental methods have been developed to study the cancer stem cells based on this characteristics. One easy method is the colony forming assay, because that stem cells are prone to grow more rapidly and make self-renewed cell populations in a colony form in culture condition 9 . In our study, β-catenin and its downstream CREB significantly increased the colony forming ability of SCC13 cells, suggesting that these molecules are important contributors for maintain the SCC via the regulating the cancer stem populations. CREB is a well-known downstream effector molecule of cAMP signaling pathway. When external and/or internal stimuli increase the cytoplasmic cAMP, the intracellular protein kinase A (PKA) is activated. The activated PKA then phosphorylates the CREB, which enables the binding of CREB to its cognate DNA sequence in certain promoter of target genes 10 . Thus, the fact that overexpression of β-catenin led to the increase of CREB in SCC13 cells suggests that activation of β-catenin signaling can also affect intracellular signaling system such as PKA. Further study is needed to elucidate the precise crosstalk between β-catenin signaling and PKA signaling pathways in SCC development and maintenance. In summary, we have demonstrated that β-catenin has a potential for promoting the growth and maintenance of SCC cells. Furthermore, we provide evidence that CREB is a downstream of β-catenin which is importantly involved in maintenance of SCC cells. Since β-catenin and downstream modulator CREB are heavily involved in the regulation of SCC cells, the data presented here suggest that these intracellular signaling may be the target for cure of SSC.
